Literature DB >> 8839783

Murine natural killer cell differentiation: past, present, and future.

T A Moore1, M Bennett, V Kumar.   

Abstract

Natural killer cells are bone marrow-derived lymphocytes capable of lysing a variety of target cells without prior exposure. While the biological activities and function of mature NK cells have been extensively investigated, the differentiation of NK cells from primitive hematopoietic stem cells is poorly understood. Recently, we have reported on the identification of a highly enriched bone marrow population capable of repopulating recipient mice with mature NK cells. In this review, we will summarize our findings and those of others in an attempt to clarify the current status of murine natural killer cell differentiation.

Entities:  

Mesh：

Year:  1996        PMID： 8839783     DOI： 10.1007/bf02918504

Source DB:  PubMed          Journal:  Immunol Res        ISSN： 0257-277X            Impact factor:   2.829


  94 in total

1.  Bone marrow clones representing an intermediate stage of development between hematopoietic stem cells and pro-T-lymphocyte or pro-B-lymphocyte progenitors.

Authors:  R Palacios; J Samaridis
Journal:  Blood       Date:  1993-03-01       Impact factor: 22.113

Review 2.  Development of B lymphocytes from lymphoid committed and uncommitted progenitors.

Authors:  A Cumano; B L Kee; D A Ramsden; A Marshall; C J Paige; G E Wu
Journal:  Immunol Rev       Date:  1994-02       Impact factor: 12.988

3.  The NK-1.1(-) mouse: a model to study differentiation of murine NK cells.

Authors:  G C Koo; F J Dumont; M Tutt; J Hackett; V Kumar
Journal:  J Immunol       Date:  1986-12-15       Impact factor: 5.422

4.  Immune responses in interleukin-2-deficient mice.

Authors:  T M Kündig; H Schorle; M F Bachmann; H Hengartner; R M Zinkernagel; I Horak
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

Review 5.  Do natural killer cells engage in regulated reactions against self to ensure homeostasis?

Authors:  G Cudkowicz; P S Hochman
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

6.  Ontogeny of Nk-1+ natural killer cells. I. Promotion of Nk-1+ cells in fetal, baby, and old mice.

Authors:  G C Koo; J R Peppard; A Hatzfeld
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

7.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor.

Authors:  S M Russell; A D Keegan; N Harada; Y Nakamura; M Noguchi; P Leland; M C Friedmann; A Miyajima; R K Puri; W E Paul
Journal:  Science       Date:  1993-12-17       Impact factor: 47.728

8.  Characterization of c-kit positive intrathymic stem cells that are restricted to lymphoid differentiation.

Authors:  Y Matsuzaki; J Gyotoku; M Ogawa; S Nishikawa; Y Katsura; G Gachelin; H Nakauchi
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

9.  Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow.

Authors:  R R Hardy; C E Carmack; S A Shinton; J D Kemp; K Hayakawa
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

10.  Rhodamine123 reveals heterogeneity within murine Lin-, Sca-1+ hemopoietic stem cells.

Authors:  C L Li; G R Johnson
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307
View more
  3 in total

1.  Generation of lytic natural killer 1.1+, Ly-49- cells from multipotential murine bone marrow progenitors in a stroma-free culture: definition of cytokine requirements and developmental intermediates.

Authors:  N S Williams; T A Moore; J D Schatzle; I J Puzanov; P V Sivakumar; A Zlotnik; M Bennett; V Kumar
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

2.  Impairment of natural killer cytotoxic activity and interferon gamma production in CCAAT/enhancer binding protein gamma-deficient mice.

Authors:  T Kaisho; H Tsutsui; T Tanaka; T Tsujimura; K Takeda; T Kawai; N Yoshida; K Nakanishi; S Akira
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

3.  Murine viral hepatitis involves NK cell depletion associated with virus-induced apoptosis.

Authors:  M Lehoux; A Jacques; S Lusignan; L Lamontagne
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.